Loading chat...
PA HB1044
Bill
Status
3/25/2025
Primary Sponsor
Arvind Venkat
Click for details
AI Summary
-
Expands Pennsylvania's epinephrine law by replacing the term "auto-injector" with "delivery system" throughout Title 35, Chapter 55, allowing authorized entities to stock and use any FDA-approved epinephrine device rather than only traditional auto-injectors
-
Defines "epinephrine delivery system" as any FDA-approved device containing a premeasured dose of epinephrine used to prevent or treat life-threatening allergic reactions
-
Authorizes trained employees or agents of authorized entities to provide or administer epinephrine delivery systems to anyone believed in good faith to be experiencing anaphylaxis, regardless of prescription status or prior allergy diagnosis
-
Maintains existing Good Samaritan liability protections for authorized entities, prescribing practitioners, pharmacists, and training providers, except in cases of intentional misconduct or gross negligence
-
Takes effect 60 days after enactment
Legislative Description
In epinephrine auto-injector entities, further providing for scope of chapter, for definitions and for epinephrine auto-injectors for authorized entities; and making an editorial change.
Last Action
Referred to Health
3/25/2025